459 related articles for article (PubMed ID: 19837417)
1. Differential diagnosis of overactive bladder in men.
Blaivas JG; Marks BK; Weiss JP; Panagopoulos G; Somaroo C
J Urol; 2009 Dec; 182(6):2814-7. PubMed ID: 19837417
[TBL] [Abstract][Full Text] [Related]
2. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer.
Blaivas JG; Weiss JP; Jones M
BJU Int; 2006 Dec; 98(6):1233-7; discussion 1237. PubMed ID: 17125481
[TBL] [Abstract][Full Text] [Related]
3. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment.
Palleschi G; Pastore AL; Stocchi F; Bova G; Inghilleri M; Sigala S; Carbone A
Clin Neuropharmacol; 2006; 29(4):220-9. PubMed ID: 16855424
[TBL] [Abstract][Full Text] [Related]
5. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder.
Kim SH; Kim TB; Kim SW; Oh SJ
J Urol; 2009 Jun; 181(6):2550-4. PubMed ID: 19375103
[TBL] [Abstract][Full Text] [Related]
6. Urodynamic classification of patients with symptoms of overactive bladder.
Flisser AJ; Walmsley K; Blaivas JG
J Urol; 2003 Feb; 169(2):529-33; discussion 533-4. PubMed ID: 12544302
[TBL] [Abstract][Full Text] [Related]
7. Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms.
Kuo HC
Urology; 2007 Aug; 70(2):272-6. PubMed ID: 17826488
[TBL] [Abstract][Full Text] [Related]
8. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
[TBL] [Abstract][Full Text] [Related]
9. Validation of the overactive bladder symptom score.
Blaivas JG; Panagopoulos G; Weiss JP; Somaroo C
J Urol; 2007 Aug; 178(2):543-7; discussion 547. PubMed ID: 17570417
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire.
Haab F; Richard F; Amarenco G; Coloby P; Arnould B; Benmedjahed K; Guillemin I; Grise P
Urology; 2008 Apr; 71(4):646-56. PubMed ID: 18313122
[TBL] [Abstract][Full Text] [Related]
11. Is the prevalence of overactive bladder overestimated? A population-based study in Finland.
Tikkinen KA; Tammela TL; Rissanen AM; Valpas A; Huhtala H; Auvinen A
PLoS One; 2007 Feb; 2(2):e195. PubMed ID: 17332843
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
[TBL] [Abstract][Full Text] [Related]
14. Male bladder control problems: a guide to assessment.
Maloney-Monaghan C; Cafiero M
Ostomy Wound Manage; 2004 Dec; 50(12):42-8. PubMed ID: 15632455
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of urodynamic findings and voiding habits in patients with concomitant benign prostatic hyperplasia and detrusor overactivity presenting with or without the symptom of urgency.
Tong YC
Urol Int; 2007; 78(3):219-25. PubMed ID: 17406130
[TBL] [Abstract][Full Text] [Related]
16. Bother related to bladder control and health care seeking behavior in adults in the United States.
Benner JS; Becker R; Fanning K; Jumadilova Z; Bavendam T; Brubaker L;
J Urol; 2009 Jun; 181(6):2591-8. PubMed ID: 19375096
[TBL] [Abstract][Full Text] [Related]
17. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
[TBL] [Abstract][Full Text] [Related]
18. Overactive bladder in children should be strictly differentiated from monosymptomatic nocturnal enuresis.
Kajiwara M; Kato M; Mutaguchi K; Usui T
Urol Int; 2008; 80(1):57-61. PubMed ID: 18204235
[TBL] [Abstract][Full Text] [Related]
19. Detrusor contractility and overactive bladder in patients with cerebrovascular accident.
Natsume O
Int J Urol; 2008 Jun; 15(6):505-10; discussion 510. PubMed ID: 18422572
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction.
Seki N; Yuki K; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2009; 28(3):197-201. PubMed ID: 18973143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
